China's First Doctor Brokerage Firm Files for IPO

▌Events & Perspectives

Before we begin the review, let me share a “bizarre” incident that I personally experienced.

Last week, I returned home in the middle of the night, starving. I rushed to a nearby convenience store, only to realize with dismay that I had just a few loose coins on me. I had no choice but to call a friend to bring me some cash...

At that moment, an elderly man walked over and asked me, “Got a light? Can I borrow a light?” Seeing that I didn’t respond, he asked again, “What are you doing?” I replied, “I’m waiting for a friend to bring me some money…” Before I could finish my sentence, the old man took off running as fast as his legs could carry him!

Am I not right......

Alright, the above was all nonsense. If any resemblance exists, I’m honored :)

Getting back to the main topic, the most sensational event in the internet healthcare circle last week was undoubtedly"The Establishment of the First Professional 'Doctor Agent' Company."

When mentioning “physician agents,” people usually think of celebrity agents first. What are the differences between them? In fact, there is little difference in nature; the biggest distinction is simply that they serve different principals.

The first of its kind is Shenzhen Guojian Medical Health Talent Service Co., Ltd. At the press conference, the company signed agreements with physician representatives, medical institutions, physician agents, law firms, and other parties, officially launching its “physician agent” business. According to the company,A qualified “physician agent” will help physicians with branding and promotion, represent them in negotiating long-term practice arrangements, safeguard their legitimate rights and interests, and assist with career advancement and the dissemination of their professional achievements.

The editor wants to ask: Do physician agents handle medical disturbances?

Additionally, let’s highlight two more “first-ever” breakthroughs.

First, the first pediatrician alliance in China has entered the field of internet healthcare.

Last week, the Hui Zhong Medical Alliance Pediatric Alliance, China’s first pediatrician alliance jointly initiated by more than 20 experts from China-Japan Friendship Hospital, Beijing Children’s Hospital, Capital Institute of Pediatrics, Peking University Third Hospital, Peking Union Medical College Hospital, People’s Hospital, Beijing Friendship Hospital, and Haidian Maternal and Child Health Hospital, was officially established.

Meanwhile, the Alliance will also formally sign a strategic cooperation agreement with "Sunshine Women and Children," a player in the mobile internet healthcare sector for women and children, to jointly build innovative products and services through an "online + offline" model.

Next, the FDA approved the first 24/7 wearable glucose monitor.

According to foreign media reports, the FDA approved the first 24/7 portable continuous glucose monitor—the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System—last week. The G5 system allows up to five “Followers” to remotely monitor the patient’sthe patient's blood glucose levels. The system also issues alerts to "followers" when abnormal data is detected. However, fingerstick blood testing is still required for determining insulin dosage and calibrating the system. Dexcom states that this device is suitable not only for adults but also for children as young as 2 years old.Usable.

By the way, Dexcom plans to launch the G5 glucose monitoring system this September.

Although the Qixi Festival has passed, the fervor for public displays of affection has remained unabated. Last week alone, four couples were formed within the internet healthcare sector.

1. Shanghai Pharmaceuticals Partners with Shanghai Ruili.

Shanghai Pharmaceuticals Group Co., Ltd. announced that Shanghai Pharmaceuticals (currently one of the largest pharmaceutical distributors in China) or its designated party is expected to invest RMB 250 million, together with Ruili Innovation Fund (a professional equity investment management institution), to establish Shanghai Jian

Kang Healthcare Industry Investment Fund (provisional name).

According to the announcement, the Shanghai Pharmaceuticals Health Medical Fund will focus its investment strategy on pharmaceutical e-commerce, new drug research and development, medical devices, and other investment opportunities within the healthcare ecosystem and across diverse scenarios.

2. Baidu Waimai Partners with Dingdang Kuaiyao to Strengthen Pharmaceutical O2O Services.

Baidu Waimai, which has just completed a $250 million financing round, announced a strategic partnership with Dingdang Kuaiyao, a subsidiary of Renhe Group. Dingdang Kuaiyao will be officially integrated into the Baidu Waimai platform, providing Baidu users with free 28-minute home delivery of medications in core areas.

Recently, the pharmaceutical O2O sector has seen significant developments, with Dianping, Meituan Waimai, and JD Daojia all vying to enter the market.

Regarding this industry phenomenon, senior figures in the pharmaceutical sector believe that pharmaceutical O2O is a cooperative model that delivers mutual benefits to patients, pharmacies, and platforms, demonstrating strong viability. It not only provides patients with transparently priced, affordable products, but also enables pharmacies to exchange logistics services for customerBy leveraging pharmaceutical services, the platform has also accumulated big data on users and products, enabling it to provide customized health management services to patients. Furthermore, with the continued advancement of the policy separating medical treatment from drug dispensing this year, the strategic significance of pharmaceutical O2O platforms has become increasingly prominent.

3. Chunyu Partners with US Telemedicine Provider USARAD.

According to mHealthWatch, USARAD Holdings, a provider of telemedicine and radiology services solutions accredited by The Joint Commission, recently announced a partnership with Chunyu Yisheng together with its subsidiary SecondOpinions, to provide third-party medical consultationinquiries, teleradiology, and specialist telemedicine services to enhance the service quality of Chunyu Doctors.

On a side note, USARAD currently operates in more than 10 countries, providing comprehensive subspecialty and general radiology interpretation services to various healthcare companies in China.

4. U.S. Pharmacy Chain Giant CVS Partners with Three Major Telemedicine Companies.

Last week, U.S. pharmacy retail giant CVS Health announced partnerships with three major telehealth companies—American Well, Doctor on Demand, and Teladoc—to explore linking telehealth providers, retail pharmacies, and retail clinic operators,improve healthcare services. Under this partnership, CVS will refer its customers to these telemedicine companies, while the three telemedicine firms will also recommend CVS’s walk-in clinics to their own customers.

CVS customers can directly access the websites of these telemedicine companies through the CVS Health website to consult with physicians online. Of course, in some cases, diagnoses must be conducted in person, such as for strep throat tests and ear examinations. In such instances, these remoteCheng Medical Company would then refer patients to CVS’s MinuteClinic. Nurse practitioners at the clinic can perform such simple examinations and assist patients in consulting with physicians via telehealth devices.

"Single dogs have been brutally crushed after watching this. Come on, let’s keep the torture going."

Bayer invests €250,000 to advance digital health.

Recently, Bayer HealthCare launched its 2015 “Grants4Apps” accelerator program in Berlin, Germany, to further drive digital innovation in the healthcare sector by supporting startups. Five digital health innovators have joined the program, eachReceived €50,000 in funding support.

Five selected digital health innovators hail from five countries across three continents: MediKeep from Estonia, Sendinaden Ltd. from China (founded by Bayer employees), Serona from the United States, Viomedo from Germany, andVitameter, a Canadian company. Its areas of expertise cover hormone testing, patient adherence, breathing patterns, clinical trials, and vitamin deficiencies. Senior executives from Bayer, along with external experts, will assist these five startups in refining their business models.

Baiyunshan Invests Another RMB 1 Billion to Co-Establish a Hospital.

Following its capital increase in Guangzhou Baiyunshan Hospital this April, GPC Baiyunshan has once again made a substantial investment in a public hospital.

Last week, Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. issued an announcement stating that it would invest RMB 1 billion to acquire a 33% equity stake, jointly establishing a venture with the Jining Municipal Health and Family Planning Commission, Shenzhen Cornerstone Venture Capital Management Co., Ltd., and the Administrative Committee of Jining High-Tech Industrial Development Zone.Partner companies invest in hospitals and participate in their construction, operation, and management.

This investment helps to expand the medical services business of GPC Baiyunshan. After two years of cultivation, the medical industry has become the fourth key development sector for the group, in addition to its three major sectors: Big Pharmaceuticals, Big Health, and Big Commerce.

Some analysts believe that, with the advancement of healthcare reform, public hospitals and medical services are emerging as a new blue ocean attracting substantial capital investment. The collaboration between GPC Baiyunshan and six hospitals in Jining City lays the foundation for future cooperation, strengthening the company’s position in the broader healthcare sector and in ShandongThe layout of the pharmaceutical market features

Evergrande Health Plans to Open 10 More Internet Hospitals and 3 Aesthetic Hospitals

Last week, Evergrande Health released its first interim financial report since going public: for the 12 months ended June 30, 2015, the company’s revenue stood at HK$416 million, a year-on-year decline of 8.74%; net profit reached HK$120 million, representing a 985.71% increase from HK$11 million in the same period last year.

At the earnings press conference, Tan Zhaohui, Chairman and Executive Director of Evergrande Health, announced the Group’s next steps in business planning. In the area of internet community hospitals, 10 additional facilities will be launched across China in the second half of the year. In medical aesthetics and anti-aging services, operations will expand to Hainan and Shanghai, Shenzhen, Chongqing and other regions, a number of Evergrande Medical Aesthetic Hospitals with distinct characteristics have been established, forming a chain service network.

For this editor living in the "Fog City," the feeling can be summed up in just one word.

Those who can still hold on, please stay strong and see what others have achieved.

And you did not.

WeChat Aims to Become an Information Hub.

Last week, the Hardware Innovation Competition, co-hosted by WeChat and the Hard Egg platform, officially concluded in Guangzhou. During the finals, the WeChat team screened a video illustrating the convenience brought to people’s lives through the connectivity between WeChat and smart devices.

According to disclosures by the WeChat team, its hardware platform has integrated more than 2,400 hardware manufacturers, with 25 million devices activated. The products primarily cover sports and health, smart home appliances, and certain pan-entertainment devices.

However, WeChat, despite its slight advantage as an information hub, is not in such a favorable position. This is because major appliance manufacturers such as Konka, TCL, and Gree have already begun to focus on mobile phone products and launch their own apps, so

Sogou Search Launches “TCM Prescription Recognition”

Following its initial foray into internet healthcare late last year—marked by a data partnership with the medical video website “Health Frontline” and the launch of a “popular science video” lookup service for medical entries—Sogou has further expanded its footprint by launching a mobile healthcare product called “TCM Prescription Identifier.””。

“TCM Prescription Recognition” leverages photo-based prescription verification as its entry point, drawing on Sogou’s extensive expertise in image recognition and search technology, along with robust big data processing capabilities, to help users decipher abstruse and complex traditional Chinese medicine prescriptions.

Judging from the two strategic initiatives, Sogou’s potential objectives have consistently centered on making professional medical knowledge more intuitive and accessible. However, compared to its previous “popular science video” service, the current “TCM Prescription Recognition” feature appears slightly

Lenovo Launches a New Smart Band Featuring an E-Ink Display.

Last week, the Lenovo Vibe Band 10 smart bracelet was officially unveiled. The VB10’s key feature is its adoption of E Ink electronic paper display technology, which provides a comfortable viewing experience and extended standby time thanks to its always-on screen. Its design incorporates a metal body and baby-grade food-safe liquid silicone.Wristband: The official store also offers a variety of interchangeable straps in multiple colors.

No matter where you are, the VB10 displays your step count in real time with a graphical activity display design, allowing you to track your daily exercise progress. You can review your historical activity data and identify exercise patterns via the mobile app. The VB10 can also sync your step count to WeChat Sports.

Lenovo Smart Band VB10 offers full compatibility with both Android and iOS systems. According to Lenovo’s official specifications, the device supports up to 7 days of continuous battery life. Downloading the dedicated app enables a more user-friendly experience and provides comprehensive health insights.

Guangzhou Pilots Online Drug Purchases Covered by Medical Insurance.

The Guangzhou Medical Insurance Bureau announced that the pilot program for online payment of pharmaceutical and medical products using personal medical insurance accounts at designated retail pharmacies has been launched in Guangzhou. Currently, only one online pharmacy, Guangyao Jianmin Network, has been included as a pilot participant.

As long as there is a sufficient balance in the personal account of the medical insurance participant, and after handling the binding business of the social security card and mobile phone number at any business outlet of the bank to which the financial account of the social security card belongs in Guangzhou, they can purchase medicines within the scope of medical insurance at designated retail pharmacies and online pharmacies according to regulations.OTC drugs, medical devices, health supplements, cosmetics with special functions, and disinfection products. After placing your order, simply wait at home for the products to be delivered to your door.

As the activation of the online payment function for social security card personal accounts involves integration with banks’ settlement and payment platforms, only five banks have currently completed this integration: Agricultural Bank of China, Guangzhou Bank, China Everbright Bank, Industrial and Commercial Bank of China, and China Construction Bank.OK.

▌VCBeat Exclusive

Make History with VCBeat: Crowdfund the “Internet Healthcare Innovation Trends Report [Cardiovascular Special]”

Top 20 Healthcare Apps Recommended by Doctors

Investors Tell You: The Few Things Founders of Internet Healthcare Companies Should Know Most

Rock Health Talks with Bessemer Venture Partners: Which Companies in the Digital Health Sector Are Worth Watching

What Do the World’s Top 10 Internet-Famous Doctors Look Like?

German Pharmaceutical Giant Bayer Joins the Ranks of Internet Healthcare Accelerators

CASS Five-Part Commentary: Has the Boom Time for Private Healthcare Arrived?

Are You a Gold Digger or a Bartender in the Healthcare Sector?

Nine M&A Deals That Could Reshape the Global Landscape of Healthcare IT in 2015

Peace of Mind Escort: The "Uber" of Medical Accompaniment

[Cardiovascular Series Report 4] 37-Degree Bracelet: Beyond Sleep and Step Counting, It Monitors Blood Pressure and Heart Rate

[Cardiovascular Series Report 5] Fengtuo Bio: All You Need Is a Suitcase to Get a Health Checkup at Home

Interpretation of Trending English Terms in Internet Healthcare:HCRM

▌Healthcare Reform

By 2020, a tiered diagnosis and treatment system suited to China’s national conditions was basically established: Chongqing Pilot ProgramChongqing Municipality is formulating the “Implementation Opinions on Launching Pilot Programs for the Tiered Diagnosis and Treatment System” (hereinafter referred to as the “Opinions”), with hypertension and diabetes designated as the initial pilot conditions.Pilot programs are planned to be launched this year in selected districts and counties that meet the necessary conditions.

This means that patients with hypertension and diabetes will receive their initial diagnosis and treatment at primary care institutions or secondary hospitals, and will be referred to higher-level hospitals if further care is required. The "Guidelines" will also specify the criteria for such referrals. Furthermore, according to the official: “"Tiered diagnosis and treatment does not mean forcing the public to seek care at primary-level institutions; rather, it primarily serves a guiding role. To this end, medical insurance will also 'tilt' support toward tiered diagnosis and treatment, leveraging its supportive incentive policies to guide patients to manage minor illnesses within their communities."

State Council Releases Administrative Measures for the Investment of Basic Pension Funds:The State Council issued the "Administrative Measures for the Investment of Basic Old-Age Insurance Funds." The Measures specify that the combined proportion of pension fund investments in stocks, equity funds, hybrid funds, and equity-oriented pension products shall not exceed30% of the net asset value of pension funds. The promulgation of the Measures also signifies the dawn of an era in which pension funds are fully entrusted for investment, with RMB 600 billion of pension capital expected to flow into the stock market.

The National Health and Family Planning Commission Releases the "Technical Guidelines for the Generation and Dissemination of Health Science Popularization Information (Trial)": The General Office of the National Health and Family Planning Commission recently issued the "Technical Guidelines for the Generation and Dissemination of Health Science Popularization Information (Trial)," providing guidance to health and family planning institutions at all levels on the generation of health science popularization informationProvide technical guidance for communication efforts.

The Guidelines require that health science popularization information adhere to the principle of scientific rigor, be supported by reliable scientific evidence (in accordance with evidence-based principles), and align with current advances and consensus in modern medicine. Priority should be given to citing industry standards, guidelines, and reports issued by government bodies, authoritative health organizations, or professional institutions.Literature supported by rigorous research methodologies and evidence. Personal or novel viewpoints should be accompanied by peer reviews from experts or institutions, or clearly disclosed to the public as representing individual expert opinions or new findings. These health science communication materials do not contain any commercial information and do not promote health-relatedInformation that contradicts health education outputs and objectives.

Note: Health science popularization information refers to content primarily based on scientific and technological knowledge, concepts, methods, and skills in the field of health, presented and disseminated in ways that are easy for the public to understand, accept, and engage with.

National Health and Family Planning Commission Issues Another Notice on Restricting Antibiotic Use: Basic Requirement for Outpatient Antibiotic Utilization Rate Is Below 20%The National Health and Family Planning Commission’s website simultaneously released the “Notice on Further Strengthening the Clinical Application Management of Antibacterial Drugs” and the “Guiding Principles for the Clinical Application of Antibacterial Drugs (2015 Edition)”)》. The former lists a series of management and evaluation indicators for the clinical application of antimicrobial drugs in its appendix.

First, requirements are proposed regarding the varieties and specifications of antimicrobial agents in various types of medical institutions. For example, the number of antimicrobial agent varieties in secondary general hospitals, stomatological hospitals, and oncology hospitals (such as co-trimoxazole [sulfamethoxazole and trimethoprim, SMZ/TMP], nitrofurantoin(excluding penicillin G, benzathine penicillin, and flucytosine from the count) shall not exceed 35 varieties; obstetrics and gynecology hospitals (maternal and child health care hospitals) are required to have no more than 40 varieties; and tertiary general hospitals and children’s hospitals shall not exceed 50 varieties.

In addition to the overall numerical limits, requirements are also imposed on drug specifications. For instance, for any given generic antimicrobial agent, no more than two formulations (whether injectable or oral) are permitted. Furthermore, antimicrobials with similar or identical pharmacological profiles must not be procured redundantly.

In terms of clinical application, evaluation indicators also include the proportion of special-use grade antimicrobial agents, antimicrobial agent usage rate, antimicrobial use intensity among inpatients, the proportion of prophylactic antimicrobial use in Class I incision surgeries, and the appropriateness of prophylactic antimicrobial use in Class I incision surgeries.conditions, etc.

▌Data

Female smartwatch users exhibit a more diverse range of app usage types, with the majority utilizing five categories:According to a survey conducted by Resonate before the Apple Watch was launched last year, early adopters of smartwatches tend to be younger and male.

Among the surveyed smartwatch users, nearly two-thirds were male (63%), with the majority aged 35 or younger. Users aged 18 to 24 accounted for 26%, while those over 44 represented only 12%.

However, compared with female users, these male smartwatch users utilize fewer types of mobile applications. Resonate surveyed the application usage patterns of smartwatch users (not limited to the smartwatch itself); the majority of female respondents selected five app categories, using only one type.Over 50% of the app’s respondents were male. Usage rates for gaming and sports apps were comparable, each accounting for 49%, followed closely by social networking at 47%.

To date, although companies’ forecasts for smartwatch adoption vary significantly, all of them anticipate substantial growth in this category next year.

The market size of China's medical oxygen industry is estimated to reach 14.3 billion yuan in 2015:The "2015-2020 China Medical Oxygen Market Research and Forecast Report" released by AskCI Consulting pointed out that in 2014, China's medical oxygen production was 6.28 billion liters, a year-on-year increase of 7.4%; in 2015China's medical oxygen industry market size is projected to reach RMB 14.3 billion.

Medical oxygen is primarily used for the prevention and treatment of hypoxia in patients, serving as an adjunctive therapy for respiratory diseases (such as asthma, bronchitis, and cor pulmonale) and cardiovascular and cerebrovascular disorders (such as coronary heart disease, myocardial infarction, cerebral hemorrhage, and cerebral infarction), to alleviate their hypoxic symptoms.status; it can also be used for health-oriented oxygen inhalation or for the rapid relief of fatigue following intense mental or physical exertion.

As the number of patients with respiratory, cardiac, and cerebrovascular diseases in China continues to rise year by year, and as living standards improve with growing public awareness of health, the demand for medical oxygen among healthcare institutions has been steadily increasing, thereby driving the medical oxygengrowth in market size. Researchers at the China Business Industry Research Institute project that by 2020, the market size of China's medical oxygen industry is expected to exceed RMB 20 billion.

Note: Medical oxygen refers to oxygen separated from the atmosphere by cryogenic distillation, used clinically for the prevention and treatment of hypoxia. The oxygen content in medical oxygen shall be not less than 99.5% (mL/mL) and shall comply with the requirements specified in the Chinese Pharmacopoeia (2010 Edition, Volume II).

Multiple Myeloma Market Expected to Reach $9 Billion in 2021:According to a report by the foreign commercial intelligence agency GBI Research, the global multiple myeloma therapy market is projected to grow from $7.3 billion in 2014 to $8.9 billion in 2021, with a relatively moderate compound annual growth rate.4.6%.

According to a report by GBI Research, growth in the multiple myeloma therapeutics market is primarily concentrated in the following eight regional markets: the United States, the United Kingdom, France, Germany, Italy, Spain, Japan, and Canada, with the aging population being the main driver of this growth.the resulting continuous rise in incidence rates.

▌New Technologies

STM: Novel “Mutation-Tracking” Blood Test Predicts Breast Cancer Recurrence

Scientists Have Developed a Blood Test for Breast Cancer That Can Identify Which Patients Will Experience Recurrence After Treatment

Researchers at the Cancer Institute are able to track key mutations as cancer accumulates, develops, and spreads, without the need for biopsies. They hope to identify potentially lethal specific mutations in patients by deciphering DNA codes in blood samples, and adjust treatments accordingly.

The study also demonstrates how genetic mutations evolve in cancer over time, as well as the growth and spread of residual cancer cells. This underscores the importance of detecting early disease recurrence, enabling patients to receive treatment before mutations emerge.

Scientists Build Bionic Brain to Map 100 Billion Neurons

Researchers at the Royal Melbourne Institute of Technology (RMIT) in Australia have recently figured out how to create devices with biomimetic memory. At first glance, this may seem like merely an advance in novel gadgets, but the reality is that they can store information like the human brain. This hasIt is akin to transitioning from the bygone era when cameras could only capture black-and-white photos to the present day, where we can now “reconstruct memories through full-color images with variations in depth, light and shadow, and texture.”

Researchers anticipate that within a few years, this invention will spur advances in the fabrication of more powerful miniature chips. These new memory elements may well serve as the foundation for constructing bionic brains, thereby propelling forward one of the most sought-after frontiers in robotics research: artificial intelligence.Development.

3D-Printed Microrobotic Fish for Detoxification and Medical Applications

Researchers at the University of California, San Diego have 3D-printed miniature 3D robotic fish that are thinner than a human hair. These microrobots could one day deliver drugs to specific locations in the body and detect and eliminate toxins. The currently printed miniature 3D robotic fish are self-propelled., magnetic manipulation enables autonomous propulsion in hydrogen peroxide solution.

New Technology Accelerates Natural Tooth Repair; Dentists May Say Goodbye to Drills

UK-based Reminova has developed a new technology that promises to replace mechanical cavity cleaning by accelerating the natural repair process of teeth. It delivers healthy calcium and phosphate minerals into the enamel, where they bind with and replenish existing enamel through a natural process.Enamel.

And remind people that brushing teeth regularly with fluoride toothpaste helps prevent cavities from the start.

Canadian Study Finds: Neuronal "Overheating" Triggers Parkinson's Disease

A study by the University of Montreal in Canada has found that the death of midbrain cells in Parkinson’s disease may be caused by a form of cellular energy crisis in neurons, which require very high levels of energy to perform motor regulation tasks. The findings were published in the journal Current Biology.。

Australian Scientists Develop Smart Bandage That Automatically Releases Antibiotics and Features Reminder Function

Smart Bandage Developed by Scientists from Two Top Australian Universities Can Treat Injuries, Alert Patients, and Warn Doctors

Due to their use of nanotechnology in wound dressing devices. The new generation of smart bandages can alert patients or doctors when there is a change in wound color, and can also automatically release antibiotics from polymer capsules. Connected to smartphones via Bluetooth technology, the bandage'sThe sensor can notify physicians when wound treatment is required.

The report states that, if adopted, this product could reduce Australia’s annual wound care costs by AUD 3 billion.

▌Capital